Skip to main content

Closed

LIMN: Liminatus Pharma, Inc. Class A Common Stock Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

0thpctl

Volume

0.15×avg

Market Cap

2.76MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Liminatus Pharma, Inc. Class A Common Stock

LIMNNASDAQ Global Select·USD·Closed

Liminatus Pharma, Inc. Class A Common Stock

LIMNNASDAQ·USD·Closed

$0.10

+0.88%

$0.10

+$0.00 (0.88%)

52W Range

0thpctl

Volume

0.15×avg

Mkt Cap

2.76MUSD

P/E

-0.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings